Y-Intercept (HK)’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Y-Intercept (HK)’s Portfolio SLGC Stock Details SLGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-36,846	Closed	-$296K	–	1273
2022 Q1	$296K	Buy	+36,846	New	+$325K	0.07%	452

Other funds holding SLGC

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MAM

Madryn Asset Management New York $34.1M AUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

FCMV

Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Y-Intercept (HK)'s SLGC Position: Q2 2022 in Review

Y-Intercept (HK) sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q2 2022, closing a stake of 36,846 shares — an estimated $296K sold.

Y-Intercept (HK) first reported a position in SLGC in Q1 2022 and held it in 1 quarter. The position peaked at $296K in Q1 2022. 135 funds tracked by Wall St. Rank hold SLGC as of Q2 2022.

Y-Intercept (HK) reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q2 2022 after selling out during the quarter.
Y-Intercept (HK) sold 36,846 SomaLogic, Inc. Class A Common Stock shares in Q2 2022, an estimated $296K.
Y-Intercept (HK) first reported a position in SomaLogic, Inc. Class A Common Stock in Q1 2022 and held it in 1 quarter.
Y-Intercept (HK)'s SomaLogic, Inc. Class A Common Stock position peaked at $296K in Q1 2022.
135 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q2 2022.

Based on Y-Intercept (HK)'s 13F filing for Q2 2022, filed 8 Aug 2022.